Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Hoffmann

Showing results (271-280 of 312) with videos related to

Pageof 32
Sort By:
Plos Biology|February 3, 2023
LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike proteinJarrod Shilts, Thomas W M Crozier, Ana Teixeira-Silva, et al.
Nature Communications|January 9, 2020
IgA subclasses have different effector functions associated with distinct glycosylation profilesUlrike Steffen, Carolien A Koeleman, Maria V Sokolova, et al.
Nature Communications|November 27, 2021
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunizationDennis Lapuente, Jana Fuchs, Jonas Willar, et al.
Nature Communications|November 26, 2021
Spike residue 403 affects binding of coronavirus spikes to human ACE2Fabian Zech, Daniel Schniertshauer, Christoph Jung, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2020
Thiol drugs decrease SARS-CoV-2 lung injury <i>in vivo</i> and disrupt SARS-CoV-2 spike complex binding to ACE2 <i>in vitro</i>Kritika Khanna, Wilfred Raymond, Jing Jin, et al.
The Lancet. Infectious Diseases|November 23, 2023
Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccinationMetodi V Stankov, Markus Hoffmann, Rodrigo Gutierrez Jauregui, et al.
Nature Communications|March 12, 2016
Externalized decondensed neutrophil chromatin occludes pancreatic ducts and drives pancreatitisMoritz Leppkes, Christian Maueröder, Sebastian Hirth, et al.
Cellular & Molecular Immunology|November 3, 2020
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methodsBerislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, et al.
Ebiomedicine|March 7, 2021
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activityMarkus Hoffmann, Heike Hofmann-Winkler, Joan C Smith, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 28, 2022
Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19Kritika Khanna, Wilfred W Raymond, Jing Jin, et al.
Pageof 32

Showing results (271-280 of 312) with videos related to

Sort By:
Pageof 32
Plos Biology|February 3, 2023
LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike proteinJarrod Shilts, Thomas W M Crozier, Ana Teixeira-Silva, et al.
Nature Communications|January 9, 2020
IgA subclasses have different effector functions associated with distinct glycosylation profilesUlrike Steffen, Carolien A Koeleman, Maria V Sokolova, et al.
Nature Communications|November 27, 2021
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunizationDennis Lapuente, Jana Fuchs, Jonas Willar, et al.
Nature Communications|November 26, 2021
Spike residue 403 affects binding of coronavirus spikes to human ACE2Fabian Zech, Daniel Schniertshauer, Christoph Jung, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2020
Thiol drugs decrease SARS-CoV-2 lung injury <i>in vivo</i> and disrupt SARS-CoV-2 spike complex binding to ACE2 <i>in vitro</i>Kritika Khanna, Wilfred Raymond, Jing Jin, et al.
The Lancet. Infectious Diseases|November 23, 2023
Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccinationMetodi V Stankov, Markus Hoffmann, Rodrigo Gutierrez Jauregui, et al.
Nature Communications|March 12, 2016
Externalized decondensed neutrophil chromatin occludes pancreatic ducts and drives pancreatitisMoritz Leppkes, Christian Maueröder, Sebastian Hirth, et al.
Cellular & Molecular Immunology|November 3, 2020
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methodsBerislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, et al.
Ebiomedicine|March 7, 2021
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activityMarkus Hoffmann, Heike Hofmann-Winkler, Joan C Smith, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 28, 2022
Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19Kritika Khanna, Wilfred W Raymond, Jing Jin, et al.
Pageof 32